中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 38 Issue 6
Jun.  2022
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2022  >  38(6): 1341-1346

Inhibitory effect of lidocaine on Kupffer cell inflammatory response and its effect on liver abscess formation in diabetic mice

DOI: 10.3969/j.issn.1001-5256.2022.06.023

  • Department of Emergency, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China

Research funding:

Scientific Research and Development Fund of Beijing Shijitan Hospital (2016-Q18);

Open Project of Beijing Key Laboratory (2019-KF04)

More Information
  • Corresponding author: WANG Ruibin, wangruibin@bjsjth.cn(ORCID: 0000-0001-9592-1539)
  • Received Date: 2021-10-18
  • Accepted Date: 2022-01-04
  • Published Date: 2022-06-20
    Abstract
  •   Objective  To investigate whether lidocaine can reverse Kupffer cell dysfunction in diabetic mice, as well as the mechanism of lidocaine in affecting liver abscess formation by improving the phagocytic function of Kupffer cells.  Methods  C57BLKS/J db/db mice were divided into diabetes control group and diabetes+lidocaine group, and C57BLKS/J db/m mice were divided into non-diabetes control group and non-diabetes+lidocaine group, with 5 mice in each group. All mice were fed with the suspension of Klebsiella pneumoniae. Kupffer cells were collected from each group and were cultured in vitro; an electron microscope was used to measure the change in ultrastructure, and Kupffer c ells were measured in terms of the levels of inflammatory mediators, the expression level of intercellular adhesion molecule-1 (ICAM-1), the chemotactic function of neutrophils, and phagocytic function; liver abscess formation was also observed. The Kruskal-Wallis H test was used for comparison of continuous data between multiple groups, and the Mann-Whitney U test was used for further comparison between two groups; the chi-square test was used for comparison of categorical data between groups.  Results  Compared with the non-diabetic mice, the diabetic mice had significant reductions in mitochondria and rough endoplasmic reticulum, endoplasmic reticulum dilation, mitochondrial swelling, and an increase in lipid droplets in Kupffer cells. Compared with the non-diabetes control group, the diabetes control group had significant increases in the levels of nitric oxide (NO) (4.95±0.06 μmol/L vs 1.34±0.13 μmol/L, P < 0.05), interleukin-6 (IL-6) (740.04±8.58 pg/mL vs 515.77±4.62 pg/mL, P < 0.05), tumor necrosis factor-α (TNFα) (774.23±7.98 pg/mL vs 461.51±1.76 pg/mL, P < 0.05), interferon gamma (IFNγ) (842.33±14.79 pg/mL vs 542.47±6.75 pg/mL, P < 0.05), and ICAM-1 (2.40±0.02 vs 1.33±0.01, P < 0.05) in Kupffer cells, a significant increase in neutrophil chemotaxis (100.80±10.18 vs 13.80±3.70, P < 0.05), and a significant reduction in phagocytic capacity (9.86±1.82 vs 60.00±3.54, P < 0.05), with no effect on liver abscess formation (40% vs 0, P > 0.05). Compared with the diabetes control group, the diabetes+lidocaine group had significant reductions in the levels of NO (3.35±0.28 μmol/L vs 4.95±0.06 μmol/L, P < 0.05), IL-6 (688.42±36.34 pg/mL vs 740.04±8.58 pg/mL, P < 0.05), TNFα (631.15±4.30 pg/mL vs 774.23±7.98 pg/mL, P < 0.05), IFNγ (704.56±3.64 pg/mL vs 842.33±14.79 pg/mL, P < 0.05), and ICAM-1 (1.50±0.02 vs 2.40±0.02, P < 0.05) in Kupffer cells, a significant reduction in neutrophil chemotaxis (33.40±5.60 vs 100.80±10.18, P < 0.05), and a significant increase in phagocytic capacity (49.20±2.59 vs 9.86±1.82, P < 0.05), with no effect on liver abscess formation (0 vs 40%, P > 0.05).  Conclusion  Lidocaine can inhibit Kupffer cell inflammatory response and improve the phagocytic function of Kupffer cells in diabetic mice, thereby exerting a protective effect on Kupffer cells, but it had no effect on liver abscess formation.

     

    • FullText(HTML)
  • loading
    • References(29)
  • [1]
    NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population- based studies with 4.4 million participants[J]. Lancet, 2016, 387(10027): 1513-1530. DOI: 10.1016/S0140-6736(16)00618-8.
    [2]
    FENG J. Retrospective analysis of clinical features and risk factors of patients with diabetic bacterial hepatic abscess complicated with hepatobiliary and pancreatic diseases[J]. J Hepatobiliary Surg, 2020, 28(6): 423-426. DOI: 10.3969/j.issn.1006-4761.2020.06.008.

    冯静. 回顾性分析糖尿病细菌性肝脓肿患者合并肝胆胰疾病的临床特点及危险因素[J]. 肝胆外科杂志, 2020, 28(6): 423-426. DOI: 10.3969/j.issn.1006-4761.2020.06.008.
    [3]
    ATREJA A, KALRA S. Infections in diabetes[J]. J Pak Med Assoc, 2015, 65(9): 1028-1030.
    [4]
    PAN JZ, WANG XM, HUANG YQ, et al. Clinical analysis of 424 cases of diabetes mellitus complicated with bacterial liver abscess[J]. Chin J Clin Infect Dis, 2021, 14(3): 199-202. DOI: 10.3760/cma.j.issn.1674-2397.2021.03.007.

    潘教治, 王仙敏, 黄友全, 等. 糖尿病合并细菌性肝脓肿424例临床分析[J]. 中华临床感染病杂志, 2021, 14(3): 199-202. DOI: 10.3760/cma.j.issn.1674-2397.2021.03.007.
    [5]
    WOHLLEBER D, KNOLLE PA. The role of liver sinusoidal cells in local hepatic immune surveillance[J]. Clin Transl Immunology, 2016, 5(12): e117. DOI: 10.1038/cti.2016.74.
    [6]
    DONG B, ZHOU Y, WANG W, et al. Vitamin D receptor activation in liver macrophages ameliorates hepatic inflammation, steatosis, and insulin resistance in mice[J]. Hepatology, 2020, 71(5): 1559-1574. DOI: 10.1002/hep.30937.
    [7]
    HOTAMISLIGIL GS. Inflammation, metaflammation and immunometabolic disorders[J]. Nature, 2017, 542(7640): 177-185. DOI: 10.1038/nature21363.
    [8]
    BILZER M, ROGGEL F, GERBES AL. Role of Kupffer cells in host defense and liver disease[J]. Liver Int, 2006, 26(10): 1175-1186. DOI: 10.1111/j.1478-3231.2006.01342.x.
    [9]
    DASU MR, DEVARAJ S, ZHAO L, et al. High glucose induces toll-like receptor expression in human monocytes: Mechanism of activation[J]. Diabetes, 2008, 57(11): 3090-3098. DOI: 10.2337/db08-0564.
    [10]
    KANETO H, KATAKAMI N, MATSUHISA M, et al. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis[J]. Mediators Inflamm, 2010, 2010: 453892. DOI: 10.1155/2010/453892.
    [11]
    TABET F, LAMBERT G, CUESTA TORRES LF, et al. Lipid-free apolipoprotein A-I and discoidal reconstituted high-density lipoproteins differentially inhibit glucose-induced oxidative stress in human macrophages[J]. Arterioscler Thromb Vasc Biol, 2011, 31(5): 1192-1200. DOI: 10.1161/ATVBAHA.110.222000.
    [12]
    YUAN T, LI Z, LI X, et al. Lidocaine attenuates lipopolysaccharide-induced inflammatory responses in microglia[J]. J Surg Res, 2014, 192(1): 150-162. DOI: 10.1016/j.jss.2014.05.023.
    [13]
    International Diabetes Federation: A global emergency. IDF diabetes atlas seventh edition[C]. Belgium: International Diabetes Federation, 2015: 11-13.
    [14]
    PEARSON-STUTTARD J, BLUNDELL S, HARRIS T, et al. Diabetes and infection: Assessing the association with glycaemic control in population-based studies[J]. Lancet Diabetes Endocrinol, 2016, 4(2): 148-158. DOI: 10.1016/S2213-8587(15)00379-4.
    [15]
    BALMER ML, SLACK E, de GOTTARDI A, et al. The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota[J]. Sci Transl Med, 2014, 6(237): 237ra66. DOI: 10.1126/scitranslmed.3008618.
    [16]
    CHEN YC, LIN CH, CHANG SN, et al. Epidemiology and clinical outcome of pyogenic liver abscess: An analysis from the National Health Insurance Research Database of Taiwan, 2000-2011[J]. J Microbiol Immunol Infect, 2016, 49(5): 646-653. DOI: 10.1016/j.jmii.2014.08.028.
    [17]
    FOO NP, CHEN KT, LIN HJ, et al. Characteristics of pyogenic liver abscess patients with and without diabetes mellitus[J]. Am J Gastroenterol, 2010, 105(2): 328-335. DOI: 10.1038/ajg.2009.586.
    [18]
    SOHN SH, KIM KH, PARK JH, et al. Predictors of mortality in Korean patients with pyogenic liver abscess: A single center, retrospective study[J]. Korean J Gastroenterol, 2016, 67(5): 238-244. DOI: 10.4166/kjg.2016.67.5.238.
    [19]
    GREGORY SH, COUSENS LP, van ROOIJEN N, et al. Complementary adhesion molecules promote neutrophil-Kupffer cell interaction and the elimination of bacteria taken up by the liver[J]. J Immunol, 2002, 168(1): 308-315. DOI: 10.4049/jimmunol.168.1.308.
    [20]
    OZCAN U, CAO Q, YILMAZ E, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes[J]. Science, 2004, 306(5695): 457-461. DOI: 10.1126/science.1103160.
    [21]
    LOHMANN-MATTHES ML, STEINMVLLER C, FRANKE-ULLMANN G. Pulmonary macrophages[J]. Eur Respir J, 1994, 7(9): 1678-1689.
    [22]
    GALASSETTI P. Inflammation and oxidative stress in obesity, metabolic syndrome, and diabetes[J]. Exp Diabetes Res, 2012, 2012: 943706. DOI: 10.1155/2012/943706.
    [23]
    HOTAMISLIGIL GS. Inflammation and metabolic disorders[J]. Nature, 2006, 444(7121): 860-867. DOI: 10.1038/nature05485.
    [24]
    ESSER N, LEGRAND-POELS S, PIETTE J, et al. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes[J]. Diabetes Res Clin Pract, 2014, 105(2): 141-150. DOI: 10.1016/j.diabres.2014.04.006.
    [25]
    DUSTIN ML, ROTHLEIN R, BHAN AK, et al. Induction by IL 1 and interferon-γ: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1)[J]. J Immunol, 1986. 137: 245-254.
    [26]
    BAKER RG, HAYDEN MS, GHOSH S. NF-κB, inflammation, and metabolic disease[J]. Cell Metab, 2011, 13(1): 11-22. DOI: 10.1016/j.cmet.2010.12.008.
    [27]
    KAUPPINEN A, SUURONEN T, OJALA J, et al. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders[J]. Cell Signal, 2013, 25(10): 1939-1948. DOI: 10.1016/j.cellsig.2013.06.007.
    [28]
    PIEGELER T, VOTTA-VELIS EG, BAKHSHI FR, et al. Endothelial barrier protection by local anesthetics: Ropivacaine and lidocaine block tumor necrosis factor-α-induced endothelial cell Src activation[J]. Anesthesiology, 2014, 120(6): 1414-1428. DOI: 10.1097/ALN.0000000000000174.
    [29]
    PIEGELER T, VOTTA-VELIS EG, LIU G, et al. Antimetastatic potential of amide- linked local anesthetics: Inhibition of lung adenocarcinoma cell migration and inflammatory Src signaling independent of sodium channel blockade[J]. Anesthesiology, 2012, 117(3): 548-559. DOI: 10.1097/ALN.0b013e3182661977.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(5)  / Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (508) PDF downloads(37) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return